Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer

Cancer Medicine

Volumn 1, Issue 1, 2012, Pages 82-88

  Marklund, Linda ^a   Näsman, Anders ^b   Ramqvist, Torbjörn ^b   Dalianis, Tina ^b   Munck Wikland, Eva ^a   Hammarstedt, Lalle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

HPV; HPV prevalence; Oropharyngeal cancer; p16; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; TONGUE CANCER; TONSIL CANCER; VIRUS DETECTION; WART VIRUS;

EID: 84875470678     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.2     Document Type: Article

References (33)

1. Gillison, M. L. 2004. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin. Oncol. 31:744-754.
2. Sturgis, E. M., and P. M. Cinciripini. 2007. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110:1429-1435.
3. Shiboski, C. H., B. L. Schmidt, and R. C. Jordan. 2005. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 103:1843-1849.
4. Hammarstedt, L., H. Dahlstrand, D. Lindquist, L. Onelov, M. Ryott, J. Luo, et al. 2007. The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol. 127:988-992.
5. Attner, P., J. Du, A. Nasman, L. Hammarstedt, T. Ramqvist, J. Lindholm, et al. 2010. The role of human papillomavirus in the increased incidence of base of tongue cancer. Int. J. Cancer 126:2879-2884.
6. Nasman, A., P. Attner, L. Hammarstedt, J. Du, M. Eriksson, G. Giraud, et al. 2009. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int. J. Cancer 125:362-366.
7. Ramqvist, T., and T. Dalianis. 2010. Oropharyngeal cancer epidemic and human papillomavirus. Emerg. Infect. Dis. 16:1671-1677.
8. Fakhry, C., W. H. Westra, S. Li, A. Cmelak, J. A. Ridge, H. Pinto, et al. 2008. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl Cancer Inst. 100:261-269.
9. Ang, K. K., J. Harris, R. Wheeler, R. Weber, D. I. Rosenthal, P. F. Nguyen-Tan, et al. 2010. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363:24-35.
10. Dahlstrand, H., L. Dahlgren, D. Lindquist, E. Munck-Wikland, and T. Dalianis. 2004. Presence of human papillomavirus in tonsillar cancer is a favourable prognostic factor for clinical outcome. Anticancer Res. 24:1829-1835.
11. Lindquist, D., M. Romanitan, L. Hammarstedt, A. Nasman, H. Dahlstrand, J. Lindholm, et al. 2007. Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol. Oncol. 1:350-355.
12. Hammarstedt, L., Y. Lu, L. Marklund, T. Dalianis, E. Munck-Wikland, and W. Ye. 2011. Differential survival trends for patients with tonsillar, base of tongue and tongue cancer in Sweden. Oral Oncol. 47:636-641.
13. Chaturvedi, A. K., E. A. Engels, W. F. Anderson, and M. L. Gillison. 2008. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J. Clin. Oncol. 26:612-619.
14. Attner, P., J. Du, A. Nasman, L. Hammarstedt, T. Ramqvist, J. Lindholm, et al. 2011. Human papillomavirus and survival in patients with base of tongue cancer. Int. J. Cancer 128:2892-2897.
15. Wittekindt, C., E. Gultekin, S. J. Weissenborn, H. P. Dienes, H. J. Pfister, and J. P. Klussmann. 2005. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival. Adv. Otorhinolaryngol. 62:72-80.
16. Klussmann, J. P., E. Gultekin, S. J. Weissenborn, U. Wieland, V. Dries, H. P. Dienes, et al. 2003. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am. J. Pathol. 162:747-753.
17. Smeets, S. J., A. T. Hesselink, E. J. Speel, A. Haesevoets, P. J. Snijders, M. Pawlita, et al. 2007. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int. J. Cancer 121:2465-2472.
18. Hafkamp, H. C., E. J. Speel, A. Haesevoets, F. J. Bot, W. N. Dinjens, F. C. Ramaekers, et al. 2003. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int. J. Cancer 107:394-400.
19. Lassen, P. 2010. The role of human papillomavirus in head and neck cancer and the impact on radiotherapy outcome. Radiother. Oncol. 95:371-380.
20. Mellin Dahlstrand, H., D. Lindquist, L. Bjornestal, A. Ohlsson, T. Dalianis, E. Munck-Wikland, et al. 2005. P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res. 25:4375-4383.
21. Weinberger, P. M., Z. Yu, B. G. Haffty, D. Kowalski, M. Harigopal, J. Brandsma, et al. 2006. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J. Clin. Oncol. 24:736-747.
22. The National Board of Health and Welfare. 2008. Cancer incidence in Sweden 2008. Statistics, Sweden.
23. Hammarstedt, L., D. Lindquist, H. Dahlstrand, M. Romanitan, L. O. Dahlgren, J. Joneberg, et al. 2006. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int. J. Cancer 119:2620-2623.
24. Licitra, L., F. Perrone, P. Bossi, S. Suardi, L. Mariani, R. Artusi, et al. 2006. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J. Clin. Oncol. 24:5630-5636.
25. Hong, A. M., T. A. Dobbins, C. S. Lee, D. Jones, G. B. Harnett, B. K. Armstrong, et al. 2010. Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br. J. Cancer 103:1510-1517.
26. Hoffmann, M., T. Gorogh, S. Gottschlich, C. Lohrey, W. Rittgen, P. Ambrosch, et al. 2005. Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett. 218:199-206.
27. Klussmann, J. P., S. J. Weissenborn, U. Wieland, V. Dries, J. Kolligs, M. Jungehuelsing, et al. 2001. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92:2875-2884.
28. Dahlstrom, K. R., K. Adler-Storthz, C. J. Etzel, Z. Liu, L. Dillon, A. K. El-Naggar, et al. 2003. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin. Cancer Res. 9:2620-2626.
29. Lindel, K., K. T. Beer, J. Laissue, R. H. Greiner, and D. M. Aebersold. 2001. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92:805-813.
30. Mellin, H., S. Friesland, R. Lewensohn, T. Dalianis, and E. Munck-Wikland. 2000. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int. J. Cancer 89:300-304.
31. Singhi, A. D., and W. H. Westra. 2010. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 116:2166-2173.
32. Dahlgren, L., H. M. Dahlstrand, D. Lindquist, A. Högmo, L. Björnestål, J. Lindholm, et al. 2004. Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int. J. Cancer 112:1015-1059.
33. Hoffmann, M., A. S. Ihloff, T. Gorogh, J. B. Weise, A. Fazel, M. Krams, et al. 2010. p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int. J. Cancer 127:1595-1602.